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Arthroscopy offers no benefit in 
subacromial shoulder pain
Shoulder arthroscopy is widely used, although its benefits are far 
from clear. Impingement of the rotator cuff tendons occurs frequently 
in patients aged >40 years and usually presents as a painful arc. As 
long ago as 1972, open decompression of the area was proposed, 
removing osseous spurs, often combined with tendon release and 
a bursectomy. This is generally now an arthroscopic procedure, 
frequently undertaken. 
A recent multicentre trial that covered 32 hospitals and 51 surgeons 
in the UK was reported in The Lancet. Eligible patients had subacromial 
pain for at least 3 months, with intact rotator cuff tendons, and had 
completed conservative management including exercise therapy and 
at least one steroid injection. Participants were randomly assigned to 
arthroscopic subacromial decompression, investigational arthroscopy 
only (which was a placebo), or no intervention.
Surgical groups had better outcomes from shoulder pain and 
function compared with no treatment, but this difference was not 
clinically important. In addition, surgical decompression appeared 
to offer no benefit over arthroscopy only. These findings bring into 
question the value of this operation for these indications, of which 
patients should be aware when offered surgery.
Beard DJ, Rees JL, Cook JA, et al. Arthroscopic subacromial decompression for subacromial shoulder pain 
(CSAW): A multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical 
trial. Lancet 2017 (epub 20 November 2017). https://doi.org/10.1016/S0140-6736(17)32457-1
Decreasing incidence of dementia found 
in birth cohort study
With an ageing population, the incidence of dementia appears to be 
increasing as we live longer. However, a recent analysis of the Einstein 
Aging Study, published in JAMA Neurology, shows that there is a 
declining incidence of dementia in those born after 1929. Individuals 
aged ≥70 years were enrolled in the Einstein Aging Study between 1993 
and 2015 to examine trends in dementia incidence and concomitant 
trends in cardiovascular comorbidities. In this study, 1 348 people from 
Bronx County, New York, USA, were analysed for all-cause dementia 
incidence. Participants did not have dementia at enrolment. 
The analysis showed that the incidence of dementia decreased in 
successive birth cohorts. The incidence per 100 person years was 
5.09 in birth cohorts before 1920, 3.11 between 1920 and 1924, 1.73 
between 1925 and 1929 and 0.23 in cohorts born after 1929, with the 
change point among those born after July of that year. At the same 
time, the prevalence of stroke and mycardial infarct also decreased, 
but the incidence of diabetes increased. Whether this decreasing 
incidence will contribute to a reduced burden of dementia given the 
ageing population remains to be seen.
Derby CA, Katz MJ, Lipton RB, et al. Trends in dementia incidence in a birth cohort analysis of the Einstein 
Aging Study. JAMA Neurol 2017;74(11):1345-1351. https://doi.org/10.1001/jamaneurol.2017.1964
Stenting does not improve exercise 
time in patients with medically treated 
angina
The main aim of percutaneous coronary intervention (PCI), 
colloquially called stenting, is symptom relief, generally improved 
exercise tolerance and time. However, a recent study in The Lancet 
suggests that this invasive procedure is no better than a placebo 
intervention. ORBITA is a blinded, multicentre randomised trial of 
PCI v. a placebo procedure for angina relief, carried out at five sites 
in the UK. Participants had severe (>70%) single-vessel stenosis, 
and received 6 weeks of medication optimisation after enrolment. 
Pre-randomisation assessments of cardiopulmonary exercise testing, 
symptom questionnaires and stress echocardiography were carried 
out before they were randomised 1:1 to undergo PCI or a placebo 
procedure. Follow-up was at 6 weeks, with the same assessments, 
measuring a difference in exercise time between the two groups.
Among the 230 patients randomised (105 assigned to PCI and 
95 to the placebo procedure), there was no significant difference in 
the exercise time increment between the two groups. There were, 
however, serious adverse events, including pressure wire-related 
problems and five major bleeding events, in both groups.
Al-Lamee R, Thompson D, Dehbi H-M, et al. Percutaneous coronary intervention in stable angina 
(ORBITA): A double-blind, randomised controlled trial. Lancet 2018;391(10115):31-40. https://doi.
org/10.1016/S0140-6736(17)32714-9
Patients in Africa are twice as likely 
to die after surgery as their global 
counterparts
Results from the African Surgical Outcomes Study show that patients in 
Africa are twice as likely to die after surgery compared with the global 
average for postoperative deaths. Prof. Bruce Biccard and colleagues 
carried out a 7-day international prospective observational cohort 
study of patients aged ≥18 years undergoing any inpatient surgery in 
25 countries in Africa. A total of 11 422 patients were recruited from 
247 hospitals, serving 810 000 people, served by 0.7 specialist surgeons, 
obstetricians and anaesthetists per 100 000 population, carrying out 
212 surgical procedures per 100 000 patients a year.
Patients were younger, and with a lower risk profile, than reported 
in high-income countries. In spite of this, postoperative complications 
occurred in 1 977 out of 10 885 patients, and 239 out of 11 193 patients 
died. Infection was the most common complication.
Biccard BM, Madiba TE, Kluyts H-L, et al. Perioperative patient outcomes in the African Surgical Outcomes 
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